The two-dose vaccine against Ebola virus developed by US drug maker Johnson and Johnson is safe, well tolerated and produces a strong immune response in people over the age of one, according to two new papers published in The Lancet Infectious Diseases. ...
Sepsis, a potentially life-threatening complication of an infection, is likely to kill more people by 2050 than cancer and heart attacks due to irrational use of antibiotics, said doctors and health experts here....
The Central Drug Research Institute (CDRI) has claimed that the clinical trials of antiviral drug, Umifenovir, in treatment of Covid-19, have been a successful exercise....
Six feet physical distance required to avoid the Covid-19 virus an infected person may shed when breathing or speaking may not help indoors, say researchers. ...
In continuation of the decline in daily Covid-19 cases, India registered 25,404 new infections in the last 24 hours, a 6.8 per cent decrease from the previous day, according to the Union Health Ministry's data released on Tuesday. ...
The Haryana government has reduced the mandatory 84-day gap between the two doses of the Covishield Covid-19 vaccine for foreign nationals and those travelling abroad. ...
Professor Gyaneshwer Chaubey, senior geneticist of the zoology department in the Banaras Hindu University (BHU), has said that the third wave of coronavirus would be less severe and deadly, especially for the vaccinated group of people, those who have been cured of the virus and the children....
Vaccine efficacy against severe Covid-19 is so high, even for the Delta variant, that booster doses for the general population are "not appropriate" at this stage in the pandemic, an international group of scientists argued in a review published in The Lancet....
Researchers have identified two drugs that mimic the effect of chemicals in cigarette smoke and reduce the ability of SARS-CoV-2 virus, the virus causing Covid-19, to enter cells....
Over 50 per cent of Japan's population have been fully inoculated against Covid-19, Minister in charge of the coronavirus response Yasutoshi Nishimura said. ...